Industry-funded Positive Studies Not Associated with Better Design or Larger Size
Authors:
- Winston J WarmeWWWinston J Warme
- Douglas C SchaadDSDouglas C Schaad
- Fredric M WolfFWFredric M Wolf
- Seth S LeopoldSLSeth S Leopold
- 1 April 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 457, 235-241
Abstract
Previous studies have associated commercial funding with positive outcomes in orthopaedic research. Those reports, however, failed to account for potential confounding variables that can lead to a disproportion of positive outcomes, including sample size, study design, and study quality. We tested the hypothesis that nonscientific factors (funding source, orthopaedic subspecialty, and geographic region of origin) are associated with positive study outcomes, but not the result of differences in study design, study quality, or sample size. All 747 abstracts presented at the 2004 American Academy of Orthopaedic Surgeons annual meeting underwent blinded analysis using previously published criteria. Studies that received commercial funding were more likely to conclude with positive outcomes. Subspecialty and country of origin were not associated with positive outcomes. Commercially funded studies were not more likely than non-funded studies to be well-designed. When control groups were used, those in commercially funded studies were not larger than those used in nonfunded studies. Our data suggest commercial funding was associated with positive outcomes, but we found no evidence to suggest commercially funded studies were better designed or larger than non-funded studies.Keywords
This publication has 36 references indexed in Scilit:
- Grading quality of evidence and strength of recommendationsBMJ, 2004
- Type II Error in the Spine Surgical LiteratureSpine, 2004
- Methodological Differences in Clinical Trials Evaluating Nonpharmacological and Pharmacological Treatments of Hip and Knee OsteoarthritisJAMA, 2003
- Association of Funding and Conclusions in Randomized Drug TrialsJAMA, 2003
- Scope and Impact of Financial Conflicts of Interest in Biomedical ResearchJAMA, 2003
- Funding source, trial outcome and reporting quality: are they related? Results of a pilot studyBMC Health Services Research, 2002
- THE QUALITY OF REPORTING OF RANDOMIZED TRIALS IN THE JOURNAL OF BONE AND JOINT SURGERY FROM 1988 THROUGH 2000Journal of Bone and Joint Surgery, 2002
- Conflict of interest in industrysponsored economic evaluations: Real or imagined?Current Oncology Reports, 2001
- Positive-Outcome Bias and Other Limitations in the Outcome of Research Abstracts Submitted to a Scientific MeetingJAMA, 1998
- Source of funding and outcome of clinical trialsJournal of General Internal Medicine, 1986